[Corrigendum] Role of (-)-epigallocatechin-3‑gallate in the osteogenic differentiation of human bone marrow mesenchymal stem cells: An enhancer or an inducer?

Jin,Pan; Li,Muyan; Xu,Guojie; Zhang,Kun; Zheng,Li; Zhao,Jinmin

doi:10.3892/etm.2021.9725

April-2021 Volume 21 Issue 4

Full Size Image

Journals

International Journal of Molecular Medicine

International Journal of Molecular Medicine is an international journal devoted to molecular mechanisms of human disease.

International Journal of Oncology

International Journal of Oncology is an international journal devoted to oncology research and cancer treatment.

Molecular Medicine Reports

Covers molecular medicine topics such as pharmacology, pathology, genetics, neuroscience, infectious diseases, molecular cardiology, and molecular surgery.

Oncology Reports

Oncology Reports is an international journal devoted to fundamental and applied research in Oncology.

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine is an international journal devoted to laboratory and clinical medicine.

Oncology Letters

Oncology Letters is an international journal devoted to Experimental and Clinical Oncology.

Biomedical Reports

Explores a wide range of biological and medical fields, including pharmacology, genetics, microbiology, neuroscience, and molecular cardiology.

Molecular and Clinical Oncology

International journal addressing all aspects of oncology research, from tumorigenesis and oncogenes to chemotherapy and metastasis.

World Academy of Sciences Journal

Multidisciplinary open-access journal spanning biochemistry, genetics, neuroscience, environmental health, and synthetic biology.

International Journal of Functional Nutrition

Open-access journal combining biochemistry, pharmacology, immunology, and genetics to advance health through functional nutrition.

International Journal of Epigenetics

Publishes open-access research on using epigenetics to advance understanding and treatment of human disease.

Medicine International

An International Open Access Journal Devoted to General Medicine.

April-2021 Volume 21 Issue 4

Full Size Image

Correction Open Access

[Corrigendum] Role of (-)-epigallocatechin-3‑gallate in the osteogenic differentiation of human bone marrow mesenchymal stem cells: An enhancer or an inducer?

Authors:
- Pan Jin
- Muyan Li
- Guojie Xu
- Kun Zhang
- Li Zheng
- Jinmin Zhao
View Affiliations / Copyright

Affiliations: Department of Orthopedic Surgery, The First Hospital Affiliated to Henan University, Kaifeng, Henan 475001, P.R. China, Medical and Scientific Research Center, Guangxi Medical University, Nanning, Guangxi 530021, P.R. China, Guangxi Key Laboratory of Regenerative Medicine, Guangxi Medical University, Nanning, Guangxi 530021, P.R. China

Copyright: © Jin et al. This is an open access article distributed under the terms of Creative Commons Attribution License [CC BY 4.0].
Article Number: 294
|
Published online on: January 27, 2021

https://doi.org/10.3892/etm.2021.9725
Expand metrics +

Article

Exp Ther Med 10:[Related article:] 828–834, 2015; DOI: 10.3892/etm.2015.2579

Subsequently to the publication of the above paper, the authors were alerted to the fact that, in Fig. 4, the data panel for Fig. 4H partially overlapped with the data shown for Fig. 4E, such that these data panels were erroneously derived from the same original source. After having referred back to the original data, the authors have realized that the data panel for Fig. 4H was selected incorrectly for this Figure.

Figure 4

Immunohistochemical staining of bone morphogenetic protein 2 expression in human bone marrow mesenchymal stem cells (hBMSCs) of the three groups [negative control, hBMSCs cultured with pure culture medium; experimental, cells treated with culture medium containing 2.5, 5 and 10 M μ(-)-epigallocatechin-3-gallate (EGCG); positive control, cells cultured with osteogenesis-induced culture medium]. (A-C) Staining of hBMSCs in the negative control group on days 7, 14 and 21, respectively. (D-F) Staining of hBMSCs in the 2.5 μM EGCG experimental group on days 7, 14 and 21, respectively. (G-I) Staining of hBMSCs in the 5 μM EGCG experimental group on days 7, 14 and 21, respectively. (J-L) Staining of hBMSCs in the 10 μM EGCG experimental group on days 7, 14 and 21, respectively. (M-O) Staining of hBMSCs in the positive control group on days 7, 14 and 21, respectively. The staining in the positive control group was evidently greater, while that in the other groups was dose-dependently upregulated.Magnification, x100.

The corrected version of Fig. 4 in shown opposite, featuring the correct data for Fig. 4H. Note that this error did not seriously affect the overall conclusions reported in the study. The authors are grateful to the Editor for granting them the opportunity to publish this Corrigendum, and apologize to the readership of the Journal for any inconvenience caused.

Journals

International Journal of Molecular Medicine

International Journal of Oncology

Molecular Medicine Reports

Oncology Reports

Experimental and Therapeutic Medicine

Oncology Letters

Biomedical Reports

Molecular and Clinical Oncology

World Academy of Sciences Journal

International Journal of Functional Nutrition

International Journal of Epigenetics

Medicine International

[Corrigendum] Role of (-)-epigallocatechin-3‑gallate in the osteogenic differentiation of human bone marrow mesenchymal stem cells: An enhancer or an inducer?

This article is mentioned in:

Article

Figure 4

Related Articles